Simple and Practical Mental Health

The BEST resource for mental health clinicians

  • *MENUS*
  • RESOURCES
    • Side effect handouts
    • Patient Handouts: Main page
    • How to find specific types of treatments
    • Rating scales and questionnaires (Main Menu)
    • BEST books
    • BEST apps/ websites
  • NEWS
  • QUESTIONS?
  • DAILY EMAILS
  • FAQ
  • REVIEWS
  • LOG IN
  • JOIN

Vilazodone (Viibryd®): Basic Information

Vilazodone (generic and brand-name Viibryd®) is an antidepressant that was approved by the United States Food and Drug Administration (FDA) for the treatment of major depressive disorder (in 2011.)

On this page, we present some basic information about this medication. Other articles on this website with more advanced information and tips related to this medication and/or related medications are linked to under Related Pages below.


FDA-approved indications

Treatment of major depressive disorder (MDD)


Pharmacological Effects

Vilazodone inhibits the reuptake of serotonin and is a partial agonist at serotonin 1A receptors.


Pharmacokinetics

The half-life of vilazodone is 24 hours, which is why it is not provided in an extended-release form.

Does it matter whether a patient takes vilazodone with food or not?  Let’s pay attention to this—it is important! The bioavailability of vilazodone increases by about 50% when taken with food, so it is important to tell patients that they MUST take vilazodone with food. (In order to reduce the risk of nausea, I like to say: take it immediately after a meal.)

By the way, what are other psychiatric drugs that also must be taken with food, not because they cause nausea, but because their absorption is much less if taken without food? For the answer, see https://simpleandpractical.com/psychiatric-medications-and-food/ 


Dosage and Administration

Initial: 10 mg once daily with food

Titrate: Increase to 20 mg once daily, 7 days after the initial dose. If necessary and tolerated, further increase with a minimum of 7 days between dosage increases. Recommended: 20 to 40 mg once daily with food

Maximum: 40 mg once daily

Important:

1. Dosage reduction is needed in severe hepatic impairment.

2. If vilazodone is taken with a strong CYP3A4 inhibitor (e.g. some HIV antivirals, clarithromycin, itraconazole, ketoconazole, etc.), its maximum dose should be reduced to 20 mg/day.

3. Similarly, if vilazodone is given with a strong CYP3A4 inducer (e.g., carbamazepine, barbiturates, etc.), its maximum dose may need to be increased up to 80 mg/day.

Should I reduce the dose for patients who are older, who have renal impairment, or who have liver impairment? Usually no, unless the liver impairment is severe.


Dosage forms and strengths

Tablets: 10 mg, 20 mg, 40 mg


Cost

As of June 2022, a patient paying out of pocket (without insurance) would pay about $110 for a one-month supply of either vilazodone 20 mg or 40 mg.


Important! Please refer to the full Prescribing Information (see link below) before prescribing this medication.


Related Pages

Vilazodone (Viibryd®): Efficacy

Vilazodone (Viibryd®): Pharmacological Effects

Vilazodone (Viibryd®): Drug Interactions

Vilazodone (Viibryd®): Adverse Effects

Podcast: 14 Key questions about vilazodone (Viibryd®)

Antidepressants: Index and Links

Psychopharmacology: Index and Links


References

Vilazodone (Viibryd®): An organized list of references


Copyright © 2015 to 2022, Simple and Practical Medical Education, LLC.  All rights reserved. May not be reproduced in any form without express written permission. Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter

Copyright 2016 to 2025: Simple and Practical Medical Education, LLC. All rights reserved.